Calithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022…
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that it will present the first data from its…